BONE DISEASE

por Terpos, Evangelos
Publicado 2022

Vaccination Against SARS-CoV-2 for Myeloma Patients: Do We Need a Booster Dose and How Frequent?

por Terpos, Evangelos
Publicado 2022

Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools

por Fotiou, Despina, Gavriatopoulou, Maria, Terpos, Evangelos
Publicado 2020

IMiDs for myeloma induced renal impairment

por Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios Athanasios
Publicado 2018

The extended 4-year follow-up results of the ELOQUENT-2 trial

por Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios Athanasios
Publicado 2019

Reply to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology

por Raje, Noopur, Terpos, Evangelos, Jandial, Danielle D.
Publicado 2019

The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma

por Giannakoulas, Nikolaos, Ntanasis-Stathopoulos, Ioannis, Terpos, Evangelos
Publicado 2021

Clinical Application of a New SARS-CoV-2 Antigen Detection Kit (Colloidal Gold) in the Detection of COVID-19

por Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Skvarč, Miha
Publicado 2021

BCMA in Multiple Myeloma—A Promising Key to Therapy

por Kleber, Martina, Ntanasis-Stathopoulos, Ioannis, Terpos, Evangelos
Publicado 2021

Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy

por Gkotzamanidou, Maria, Terpou, Elisavet, Kentepozidis, Nikolaos, Terpos, Evangelos
Publicado 2021

Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection

por Malandrakis, Panagiotis, Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Terpos, Evangelos
Publicado 2020

Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma

por Fotiou, Despina, Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios A.
Publicado 2022

Pathogenesis of bone disease in multiple myeloma: from bench to bedside

por Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Dimopoulos, Meletios A.
Publicado 2018

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies

por Alexopoulos, Harry, Trougakos, Ioannis P, Dimopoulos, Meletios-Athanasios, Terpos, Evangelos
Publicado 2023

The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma

por Gkotzamanidou, Maria, Terpos, Evangelos, Dimopoulos, Meletios A., Souliotis, Vassilis L.
Publicado 2022

Serological testing for SARS-CoV-2: Advancements and future challenges

por Alexopoulos, Harry, Trougakos, Ioannis P, Dimopoulos, Meletios-Athanasios, Terpos, Evangelos
Publicado 2023

Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma

por Terpos, Evangelos, Kanellias, Nikolaos, Christoulas, Dimitrios, Kastritis, Efstathios, Dimopoulos, Meletios A
Publicado 2013

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma

por Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Korompoki, Eleni, Terpos, Evangelos, Dimopoulos, Meletios A.
Publicado 2021

Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches

por Kostopoulos, Ioannis V., Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Tsitsilonis, Ourania E., Terpos, Evangelos
Publicado 2020

Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review

por Fiste, Oraianthi, Liontos, Michael, Koutsoukos, Konstantinos, Terpos, Evangelos, Dimopoulos, Meletios A., Zagouri, Flora
Publicado 2020